Market Value411,104,315
Total Holdings37
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
DNTH / Dianthus Therapeutics, Inc.
BSX / Boston Scientific Corporation
KPTI / Karyopharm Therapeutics Inc.
SLNO / Soleno Therapeutics, Inc. Call
SNDX / Syndax Pharmaceuticals, Inc.
KPTI / Karyopharm Therapeutics Inc.
EW / Edwards Lifesciences Corporation
OM / Outset Medical, Inc.
VIR / Vir Biotechnology, Inc.
ADPT / Adaptive Biotechnologies Corporation
ISRG / Intuitive Surgical, Inc.
QURE / uniQure N.V.
LIVN / LivaNova PLC
MGX / Metagenomi, Inc.
TARA / Protara Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
SEPN / Septerna, Inc.
MRSN / Mersana Therapeutics, Inc.
KYTX / Kyverna Therapeutics, Inc.
GUTS / Fractyl Health, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ZBIO / Zenas BioPharma, Inc.
VCYT / Veracyte, Inc.
CYTK / Cytokinetics, Incorporated
FULC / Fulcrum Therapeutics, Inc.
NARI / Inari Medical, Inc.
EXAS / Exact Sciences Corporation
IRON / Disc Medicine, Inc.
ADMA / ADMA Biologics, Inc.
MASI / Masimo Corporation
BMY / Bristol-Myers Squibb Company
BPMC / Blueprint Medicines Corporation
INSP / Inspire Medical Systems, Inc.
BDX / Becton, Dickinson and Company
ATAI / Atai Life Sciences N.V.
KROS / Keros Therapeutics, Inc.
HYPR / Hyperfine, Inc.
NVST / Envista Holdings Corporation
ARQT / Arcutis Biotherapeutics, Inc. Put
REGN / Regeneron Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
MLTX / MoonLake Immunotherapeutics
SNSE / Sensei Biotherapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SLNO / Soleno Therapeutics, Inc.
REPL / Replimune Group, Inc.
LLY / Eli Lilly and Company